Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
24 Feb 2021 Annual Corporate Governance Report ROVI releases the 2020 Annual Corporate Governance Report Download
24 Feb 2021 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors  Download
11 Jan 2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2020 Download
24 Nov 2020 On business and financial situation The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day. Download
13 Nov 2020 Other relevant information The Company informs about the dividends payment  Download

Pages

Date Title Description PDF
08 Oct 2018 Share capital increases and reductions Information on the registration in the Commercial Registry of Madrid of the notarial deed regarding the capital increase Download
05 Oct 2018 Buy-back programmes, stabilisation and treasury stock Information about the possibility that Jefferies International Limited carries out stabilisation transactions within the framework of the capital increase excluding pre-emptive subscription rights of the existing shareholders of Laboratorios Farmacéuticos Rovi, S.A. Download
04 Oct 2018 Share capital increases and reductions Directors’ Report and Independent Expert Report related to capital increase excluding preferential subscription rights Download
04 Oct 2018 Liquidity contracts and specialists The Company informs that has temporarily suspended liquidity agreement with JB Capital Markets, Sociedad de Valores, S.A.U. Download
04 Oct 2018 Share capital increases and reductions Information on price fixing and outcome of the private placement related to capital increase addressed to institutional investors, excluding preferential subscription rights Download

Pages